Literature DB >> 2478443

Primary mucinous adenocarcinoma of the lung with signet-ring cells: a histochemical comparison with signet-ring cell carcinomas of other sites.

J K Kish1, J Y Ro, A G Ayala, M J McMurtrey.   

Abstract

Five cases of primary mucinous adenocarcinomas of the lung with signet-ring cells were studied with regard to clinical, pathologic, and prognostic implications and compared with the signet-ring cell adenocarcinomas of extrapulmonary sites. The patients ranged in age from 55 to 74 years, with a mean age of 67.8 years. There were three men and two women. Histologically, three cases were usual adenocarcinomas and two were bronchioloalveolar carcinomas. The percentage of signet-ring cells ranged from 10% to 50%, with a mean of 22% and a median of 20%. Therapy included lobectomy, radiation, and chemotherapy. Three of five patients died of their disease within 9 months and two patients showed no evidence of disease 5 months after presentation. Routine histology showed no significant differences between the signet-ring cells of any of the tumors; however, by special histochemistry, tumors originating from lung, stomach, and colon showed a more intense reaction with alcian blue stain than tumors from nose, breast, or bladder. Contrary to a previous report, we found no increase in sulfated acid mucins in these five cases of lung tumor. We also were unable to demonstrate a qualitative or quantitative difference between mucopolysaccharides produced by lung, stomach, or colon tumors. Although rare, mucinous adenocarcinoma of the lung with signet-ring cells can exist as a primary tumor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478443     DOI: 10.1016/0046-8177(89)90229-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts.

Authors:  Jennifer M Boland; Jason A Wampfler; Jin S Jang; Xiaoke Wang; Michele R Erickson-Johnson; Andre M Oliveira; Ping Yang; Jin Jen; Eunhee S Yi
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

2.  Primary signet-ring cell carcinoma of the lung treated with crizotinib: A case report.

Authors:  Yue-Qin Hao; Hua-Ping Tang; Hong-Yun Liu
Journal:  Oncol Lett       Date:  2015-03-02       Impact factor: 2.967

3.  Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report.

Authors:  Eunice Choi; Annisa L Lewis; Hidehiro Takei; Jae Y Ro
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

4.  Primary signet ring cell carcinoma of the lung with cerebellar metastasis showing full response to Cisplatin and docetaxel therapy.

Authors:  Onur Kocas; Fatih Selcukbiricik; Ahmet Bilici; Metin Kanıtez; Serdar Yildiz; Suna Avci; Canan Tanik
Journal:  Case Rep Oncol Med       Date:  2014-01-09

5.  Clinicopathologic and molecular characteristics of lung adenocarcinoma arising in young patients.

Authors:  Lucia Kim; Kyu Ho Kim; Yong Han Yoon; Jeong Seon Ryu; Suk Jin Choi; In Suh Park; Jee Young Han; Joon Mee Kim; Young Chae Chu
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

6.  Survival analyses and immunohistochemical study of primary signet ring cell carcinoma of the lung adenocarcinoma.

Authors:  Chunji Chen; Lei Wang; Chang Gu; Yiyang Wang; Xufeng Pan; Shijie Fu; Jun Yang; Rui Wang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

Review 7.  Invasive mucinous adenocarcinoma of the lung.

Authors:  Lu Xu; Chenghui Li; Hongyang Lu
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

8.  Clinicopathological characteristics and survival in lung signet ring cell carcinoma: a population-based study.

Authors:  Yunting Cai; Yan Xie; Yanli Xiong; Wei Guan; Yu Pu; Dong Wang; Mingfang Xu; Shenglan Meng
Journal:  Bosn J Basic Med Sci       Date:  2021-12-01       Impact factor: 3.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.